KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Revenue: 2009-2025

Historic Revenue for Bausch Health Companies (BHC) over the last 17 years, with Sep 2025 value amounting to $2.7 billion.

  • Bausch Health Companies' Revenue rose 6.81% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 billion, marking a year-over-year increase of 5.86%. This contributed to the annual value of $9.6 billion for FY2024, which is 9.91% up from last year.
  • Latest data reveals that Bausch Health Companies reported Revenue of $2.7 billion as of Q3 2025, which was up 5.97% from $2.5 billion recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Revenue ranged from a high of $7.2 billion in Q4 2021 and a low of $1.9 billion during Q1 2022.
  • Moreover, its 3-year median value for Revenue was $2.4 billion (2024), whereas its average is $2.4 billion.
  • Per our database at Business Quant, Bausch Health Companies' Revenue soared by 227.16% in 2021 and then slumped by 69.71% in 2022.
  • Quarterly analysis of 5 years shows Bausch Health Companies' Revenue stood at $7.2 billion in 2021, then crashed by 69.71% to $2.2 billion in 2022, then increased by 9.80% to $2.4 billion in 2023, then grew by 6.27% to $2.6 billion in 2024, then climbed by 6.81% to $2.7 billion in 2025.
  • Its last three reported values are $2.7 billion in Q3 2025, $2.5 billion for Q2 2025, and $2.3 billion during Q1 2025.